| Select | PubMed ID | Description |
| 1526648 | Immunology. 1992 Jul;76(3):389-96.
Recombinant pollen allergens from Dactylis glomerata: preliminary evidence that
human IgE cross-reactivity between Dac g II and Lol p I/II is increased following
grass pollen immunotherapy.
Roberts AM(1), Van Ree R, Cardy SM, Bevan LJ, Walker MR.
|
| 7518655 | Allergy. 1994 Apr;49(4):254-61.
IgE and IgG cross-reactivity among Lol p I and Lol p II/III. Identification of
the C-termini of Lol p I, II, and III as cross-reactive structures.
van Ree R(1), van Leeuwen WA, van den Berg M, Weller HH, Aalberse RC.
|
| 7691817 | J Biol Chem. 1993 Oct 15;268(29):21819-25.
Cloning, expression, and immunological characterization of recombinant Lolium
perenne allergen Lol p II.
Sidoli A(1), Tamborini E, Giuntini I, Levi S, Volonté G, Paini C, De Lalla C,
Siccardi AG, Baralle FE, Galliani S, et al.
|
| 9117883 | Clin Exp Allergy. 1997 Jan;27(1):68-74.
Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1,
2, 3 and 5) during immunotherapy.
Van Ree R(1), Van Leeuwen WA, Dieges PH, Van Wijk RG, De Jong N, Brewczyski PZ,
Kroon AM, Schilte PP, Tan KY, Simon-Licht IF, Roberts AM, Stapel SO, Aalberse RC.
|
| 19585971 | J Proteome Res. 2009 Sep;8(9):4383-91. doi: 10.1021/pr900315a.
Novel IgE recognized components of Lolium perenne pollen extract: comparative
proteomics evaluation of allergic patients sensitization profiles.
De Canio M(1), D'Aguanno S, Sacchetti C, Petrucci F, Cavagni G, Nuccetelli M,
Federici G, Urbani A, Bernardini S.
|
